Medistri is a Swiss service provider supporting medical device and pharmaceutical manufacturers from pre-clinical development to industrialization, with integrated sterilization, laboratory, packaging validation, and manufacturing services, ensuring compliance and product safety.
Products, services, technology
Medistri delivers integrated sterilization, laboratory testing, packaging validation, manufacturing, consulting, and logistics services, supported by qualified technologies, validated processes, and digital tools ensuring compliance, traceability, and operational reliability.
Cooperation possibilities
With sites in Switzerland and Hungary and an office at Biopôle (Lausanne), Medistri offers cooperation opportunities combining proximity to the Swiss life-science ecosystem with scalable industrial capabilities, supporting partners from development through go-to-market and industrialization.
- http://www.medistri.com
- +41 26 676 90 80
- Send an email
- Bruno Martins
Some insights
Medistri contributes to public health by supporting the development, validation, and industrialization of medical device and pharmaceutical products through regulated services that ensure safety, quality, and compliance throughout the product lifecycle.
We are proud of our team’s expertise, integrity, and efficiency, and of the responsibility we carry in supporting patient safety and public health through regulated, high-quality services delivered with transparency and reliability.
Role models in our industry are organizations and institutions that set high standards for quality, patient safety, and regulatory integrity, while continuously investing in people, technology, and responsible operations.
Our team’s strengths are rooted in honesty, efficiency, and a shared focus on success, reflected in strong technical expertise, a robust quality culture, and transparent collaboration. Looking ahead, we aim to integrate skills in digitalization and innovation.
Support from the Swiss biotech ecosystem is strongest when it facilitates connections between innovators and industrial partners, enabling smoother transitions from development to scale-up within a regulated and high-quality environment.
